Literature DB >> 23582311

Urine output is associated with prognosis in patients with acute kidney injury requiring continuous renal replacement therapy.

Hyung Jung Oh1, Dong Ho Shin, Mi Jung Lee, Kwang Il Ko, Chan Ho Kim, Hyang Mo Koo, Fa Mee Doh, Young Eun Kwon, Yung Ly Kim, Ki Heon Nam, Kyoung Sook Park, Seong Yeong An, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang.   

Abstract

PURPOSE: Although some studies have found that early initiation of continuous renal replacement therapy (CRRT) is associated with better prognosis, no consensus exists on the best timing to start CRRT. We investigated whether the timing of CRRT initiation was relevant to overall mortality and explored which factors at the time of CRRT initiation were associated with better outcomes in critically ill patients with acute kidney injury (AKI).
MATERIALS AND METHODS: A total of 361 patients who received CRRT for AKI between 2009 and 2011 were collected and divided into 2 groups based on the median blood urea nitrogen (BUN) levels or 6-hour urine output immediately before CRRT was started. The impact of the timing of CRRT initiation stratified by BUN concentration or urine output on 28-day all-cause mortality was compared between groups.
RESULTS: When the timing of CRRT initiation was stratified by 6-hour urine output, 28-day all-cause mortality rates were significantly lower in the nonoliguric group compared with the oliguric group (P = .02). In contrast, clinical outcomes were not different between the low-BUN and the high-BUN groups (P = .30). Cox regression analysis revealed that 28-day all-cause mortality risk was significantly lower in the nonoliguric group stratified by 6-hour urine output, even after adjusting for age, sex, mean arterial pressure, Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores, and serum biomarkers (hazard ratio, 0.85; 95% confidence interval, 0.65-0.99; P = .04).
CONCLUSIONS: Urine output but not BUN concentration was significantly associated with a better prognosis in critically ill patients with AKI requiring CRRT.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  28-Day mortality; Acute kidney injury; Blood urea nitrogen; Continuous renal replacement therapy; Urine output

Mesh:

Substances:

Year:  2013        PMID: 23582311     DOI: 10.1016/j.jcrc.2012.11.019

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  10 in total

1.  Does Changing the Volume Matter? The Relationship of Urine Volume and Dialysis Intensity.

Authors:  Christine K Federspiel; Kathleen D Liu
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-22       Impact factor: 8.237

2.  Extrarenal sequential organ failure assessment score as an outcome predictor of critically ill children on continuous renal replacement therapy.

Authors:  Won Kyoung Jhang; Young A Kim; Eun Ju Ha; Yoon Jung Lee; Ju Hoon Lee; Young Seo Park; Seong Jong Park
Journal:  Pediatr Nephrol       Date:  2014-01-29       Impact factor: 3.714

3.  Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.

Authors:  Finnian R Mc Causland; Josephine Asafu-Adjei; Rebecca A Betensky; Paul M Palevsky; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-22       Impact factor: 8.237

4.  Duration of anuria predicts recovery of renal function after acute kidney injury requiring continuous renal replacement therapy.

Authors:  Hee-Yeon Jung; Jong-Hak Lee; Young-Jae Park; Sang-Un Kim; Kyung-Hee Lee; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim; Jang-Hee Cho
Journal:  Korean J Intern Med       Date:  2016-02-12       Impact factor: 2.884

5.  Outcomes from a cohort of patients with acute kidney injury subjected to continuous venovenous hemodiafiltration: The role of negative fluid balance.

Authors:  Thais Oliveira Claizoni Dos Santos; Marisa Aparecida de Souza Oliveira; Julio Cesar Martins Monte; Marcelo Costa Batista; Virgilio Gonçalves Pereira Junior; Bento Fortunato Cardoso Dos Santos; Oscar Fernando Pavão Santos; Marcelino de Souza Durão Junior
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

6.  Cumulative fluid balance and mortality in elderly patients with acute kidney injury requiring continuous renal-replacement therapy: a multicenter prospective cohort study.

Authors:  Jong Hyun Jhee; Jae Yoon Park; Jung Nam An; Dong Ki Kim; Kwon Wook Joo; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang; Jung Pyo Lee; Jung Tak Park
Journal:  Kidney Res Clin Pract       Date:  2020-12-31

7.  Early initiation of continuous renal replacement therapy improves survival of elderly patients with acute kidney injury: a multicenter prospective cohort study.

Authors:  Jae Yoon Park; Jung Nam An; Jong Hyun Jhee; Dong Ki Kim; Hyung Jung Oh; Sejoong Kim; Kwon Wook Joo; Yun Kyu Oh; Chun-Soo Lim; Shin-Wook Kang; Yon Su Kim; Jung Tak Park; Jung Pyo Lee
Journal:  Crit Care       Date:  2016-08-16       Impact factor: 9.097

8.  Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury.

Authors:  Chen-Fei Zheng; Wen-Yue Liu; Fang-Fang Zeng; Ming-Hua Zheng; Hong-Ying Shi; Ying Zhou; Jing-Ye Pan
Journal:  Crit Care       Date:  2017-09-08       Impact factor: 9.097

9.  Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury.

Authors:  Junseok Jeon; Do Hee Kim; Song In Baeg; Eun Jeong Lee; Chi Ryang Chung; Kyeongman Jeon; Jung Eun Lee; Wooseong Huh; Gee Young Suh; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh; Hye Ryoun Jang
Journal:  Crit Care       Date:  2018-10-10       Impact factor: 9.097

10.  Clinical characteristics of sepsis-induced acute kidney injury in patients undergoing continuous renal replacement therapy.

Authors:  A Young Cho; Hyun Ju Yoon; Kwang Young Lee; In O Sun
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.